C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients

Acta Physiologica Scandinavica

Volumn 165, Issue 1, 1999, Pages 39-44

  Johansson, B L ^a   Pernow, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Forearm blood flow; Glucose uptake; Human C peptide; Vascular resistance; Venous occlusion plethysmography

Indexed keywords

C PEPTIDE; GLUCOSE; NEUROPEPTIDE Y;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; GLUCOSE TRANSPORT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL;

ADULT; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; NEUROPEPTIDE Y; PLETHYSMOGRAPHY; VASOCONSTRICTION;

EID: 0032952384     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201x.1999.00475.x     Document Type: Article

References (28)

1. Ahlborg, G. & Lundberg, J.M. 1996. Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with tye 1 diabetes. Clin Physiol 16, 645-655.
2. Clarke, J., Benjamin, N., Larkin, S., Webb, D., Maseri, A. & Davies, G. 1991. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation 83, 774-777.
3. Edvinsson, L., Emson, P., McCulloch, J., Tatemoto, K. & Uddman, R. 1983. Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett 43, 79-84.
4. Flatt, P.R., Swanston-Flatt, S.K., Hampton, S.M., Bailey, C.J. & Marks, V. 1986. Specific binding of the C-petide of proinsulin to cultured B-cells from a transplanteble rat islet cell tumor. Bioscience Reports 6, 193-141.
5. Graf, K. & Westersten, A. 1959. Untersuchungen uber Eigenschaften und Verwendungsmöglichkeiten eines Flexiblen Extremitätenplethymografen. Acta Physiol Scand 46, 1-18.
6. +-ATPase, conduction and myoinositol in the insulin dependent BB rat. Am J Physiol 241, E 534-539.
7. 1c by a new liquid-chromatographic assay: metodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32, 1867-1872.
8. Johansson, B.-L., Berg, U., Bohlin, A.-B., Lefvert, A.-K. & Freyschuss, U. 1987. Exercise-induced changes in renal function and their relation to plasma noradrenaline in insulin-dependent children and adolescents. Clin Sci 72, 611-620.
9. Johansson, B.-L., Borg, K., Fernqvist-Forbes, E., Odergren, T., Remahl, S. & Wahren, J. 1996. C-pepride improves autonomic nerve function in IDDM patients. Diabetologia 39, 687-695.
10. Johansson, B.-L. & Freyschuss, U. 1991. Physiological effects of mental stress and orthostasis in young insulin-dependent diabetic children and adolescents. Acta Paediatr Scand 80, 66-74.
11. Johansson, B.-L., Kernell, A., Sjöberg, S. & Wahren, J. 1993. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77, 976-981.
12. Johansson, B.-L., Linde, B. & Wahren, J. 1992b. Effects of C-peptide on blood flow capillary diffusion capacity and glucose utilization in Type 1 (insulin-dependent) diabetic patients. Diabetologia 35, 1151-1158.
13. Johansson, B.-L., Sjöberg, S. & Wahren, J. 1992a. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35, 121-128.
14. Michel, M.C. 1991. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci 12, 389-394.
15. + -ATPase activity in synergism with neuropeptide Y. Diabetologia 39, 199-205.
16. +-ATPase activity. Kidney Int 45, 1606-1613.
17. Pernow, J., Lundberg, J.M., Kaijser, L., et al. 1986. Plasma neuropeptide y-like immunoreacting and catecholamines during various degrees of sympathetic activation in man. Clin Physiol. 6, 561-578.
18. Pernow, J., Lundberg, J.M. & Kaijser, L. 1987. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 40, 47-54.
19. Pernow, J., Lundberg, J. & Kaijser, L. 1989. Effect of oral administration of nifedipine on neuropeptide Y-and noradrenaline-induced vasoconstriction in the human forearm. Clin Physiol 9, 67-75.
20. Raccah, D., Gallice, P., Pouget, J. & Vague, P. 1992. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of diabetic neuropathy. Diabete Metab 18, 236-241.
21. Sjöqvist, M., Huang, W. & Johansson, B.-L. 1998. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54, 758-764.
22. Steiner, D. 1978. On the role of proinsulin C-peptide. Diabetes 27 (Suppl 1), 141-148.
23. Steiner, D.F., Cunningham, D., Spigelman, L. & Aten, B. 1967a. Insulin biosynthesis: evidence for a precursor. Science 157, 697-700.
24. Steiner, D.F. & Oyer, P.E. 1967b. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57, 473-480.
25. Wahlestedt, C., Edvinsson, L., Ekblad, E. & Håkansson, R. 1985. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234, 735-741.
26. Wahlestedt, G., Håkansson, R., Vaz, C.A. & Zukowska-Grojec, Z. 1990. Norepinephrine and neuropeptide Y; vasoconstrictor cooperation in vivo and in vitro. Am J Physiol 258 (2), R736-R742.
27. Wahren, J., Johansson, B.-L., Wallberg-Henriksson, H., Linde, B., Fernqvist-Forbes, E. & Zierath, J. 1996a. C-peptide revisited - new physiolgical effects and therapeutic implications. J Int Med 240, 115-124.
28. +-ATPase activity: A negative feedback mechanism on insulin secretion? Diabetologia 39 (Suppl.1), A 71.